Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction

Post time 2021-12-28 12:00:40

journal：JAMA Cardiology

Authors：David D. Berg; Pardeep S. Jhund; Kieran F. Docherty; Sabina A. Murphy; Subodh Verma; Silvio E. Inzucchi; Lars Kober; Mikhail N. Kosiborod; Anna Maria Langkilde; Felipe A. Martinez; Olof Bengtsson; Piotr Ponikowski; Mikaela Sjostrand; Scott D. Solomon; John J. V. McMurray; Marc S. Sabatine

Published date：2021-5-1

DOI：10.1001/jamacardio.2020.7585

Article link：http://dx.doi.org/10.1001/jamacardio.2020.7585

Article Source：American Medical Association (AMA)。

Remark：

Post time 2021-12-28 12:00:41

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-28 13:39:41

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-28 14:16:32

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-28 14:17:25

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-28 15:11:37

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-28 17:14:30

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today